Evidence map›Paper›PMID 27465399›Full record

ArticleJournal of hematology & oncology2016

Short telomere length and its correlation with gene mutations in myelodysplastic syndrome.

Sang Mee Hwang, Seon Young Kim, Jung Ah Kim, Hee-Sue Park, Si Nae Park, Kyongok Im, Kwantae Kim, Sung-Min Kim, Dong Soon Lee

Abstract read
In one paragraph

Article in Journal of hematology & oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Prognostic significance ofThe Journal of international medical research · 2020
    Pooled it
  2. Pooled it
  3. Abnormal mRNA Expression Levels of Telomere-Binding Proteins Represent Biomarkers in Myelodysplastic Syndromes: A Case-Control Study.Turkish journal of haematology : official journal of Turkish Society of Haematology · 2017
    Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Telomere integrated scoring system of myelodysplastic syndrome.Journal of clinical laboratory analysis · 2023
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Telomere biology disorders.NPJ genomic medicine · 2021
    Review
  15. Article
  16. Review
  17. Article
  18. Short Dysfunctional Telomere Is Highly Predictive of Dismal Outcome in MDS but Not in AML Patients.International journal of hematology-oncology and stem cell research · 2020
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sang Mee HwangDepartment of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Seon Young KimDepartment of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
Jung Ah KimDepartment of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Hee-Sue ParkDepartment of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Si Nae ParkCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kyongok ImCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kwantae KimCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Sung-Min KimCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Dong Soon LeeDepartment of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. soonlee@snu.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTelomere erosion can lead to genomic instability and cancer progression. It has been suggested that the shortest telomere, not the average telomere length (TL), is critical for cell viability. Some studies have shown shorter TL in myelodysplastic syndrome (MDS) patients but the critically short telomeres, the variability of TL within individual patient has not been evaluated. Thus, we aimed to investigate the TL of MDS patients and assessed the association of TL with recurrent genetic mutations in MDS.

methodsWe measured the TL of bone marrow nucleated cells for diagnostic samples at a single-cell level by quantitative fluorescence in situ hybridization (Q-FISH) for 58 MDS patients and analyzed the minimum, median, average, standard deviation, average of the 0th to 10th percentile TL within a patient, and the proportion of cells with TL that is shorter than the lowest 10th percentile of the normal control (NC). The correlations of TL to clinical parameters, cytogenetic results, and genetic mutations were assessed.

resultsMDS patients showed eroded telomeres and narrow distribution compared to the NC (P < 0.001, P = 0.018, respectively). Patients with mutation showed significantly lesser cells with short TL, below the lowest 10th percentile of the NC (P = 0.017), but no differences in TL were found according to mutations/cytogenetic abnormalities except for CSF3R mutation. However, those patients with a high percentage (≥80 %) of cells with short TL showed poorer overall survival (P = 0.021), and this was an independent prognostic factor, along with TP53, U2AF1 mutation, and high BM blast count (P = 0.044, 0.001, 0.004, 0.012, respectively).

conclusionsThe shortest TL, which determines the fate of the cell, was significantly shorter, and higher burden of cells with short TL were found in MDS, which correlated with poor survival, suggesting the need to measure TL in single cells by Q-FISH.

Indexed as

MutationAdolescentAdultAgedBone Marrow CellsChromosome AberrationsFemaleGenomic InstabilityHumansIn Situ Hybridization, FluorescenceMaleMiddle AgedMyelodysplastic SyndromesSurvival RateTelomereTelomere ShorteningMutationQuantitative fluorescence in situ hybridizationSingle cellTelomere length

Identifiers

PMID27465399
PMCPMC4964031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.